期刊文献+

8株耐亚胺培南铜绿假单胞菌基因型的研究 被引量:2

A study on gene for resistance of carbapenems in 8 strains Pseudomonas aeruginosa
暂未订购
导出
摘要 目的检测8株耐碳青霉烯类抗菌药物铜绿假单胞菌携带的耐药基因以指导临床合理用药。方法 K-B琼脂扩散法做抗菌药物敏感实验,聚合酶链式反应技术(PCR)在所收集菌株中扩增BLAimp、BLAvim、OXA基因。结果用PCR技术在8株亚胺培南耐药的铜绿假单胞菌基因组中扩增出BLAimp基因。结论产金属β-内酰胺酶是我科铜绿假单胞菌对亚胺培南耐药的主要机制。实验室检测可帮助临床合理选用抗菌药物并减少耐药性的传播,防止术区感染提高临床治愈率。 Objective To investigate the gene for resistance of carbapenems in Pseudomonas aeruginosa and guide the clinical use of drugs.Methods Drug susceptibility was determined by K-B,polymerase chain reactions(PCR) was used to amplify the fragment of BLAvim,BLAimp,and OXA gene.Results The fragment of BLA imp gene was amplified simultaneously from 8 strains by polymerase chain reactions.Conclusion The mechanism of some Iipenem-resistant Pseudomonas aeruginosa which produce metallo-β-lactamase,laboratory examination assistant clinic medical using antibacterial logical and reduce the appearance rate of drug resistant,increase the cure rate of burn infection.
机构地区 解放军第 解放军第
出处 《临床军医杂志》 CAS 2012年第2期425-427,共3页 Clinical Journal of Medical Officers
关键词 骨科病区 铜绿假单胞菌 耐药性 orthopedics department Pseudomonas aeruginosa drug resistant
  • 相关文献

参考文献9

二级参考文献40

  • 1辜依海,罗燕萍,张文莉,张军民.耐亚胺培南铜绿假单胞菌的耐药性分析及金属β-内酰胺酶检测[J].中华医院感染学杂志,2005,15(3):339-341. 被引量:47
  • 2徐元宏,沈继录,杨伯侠,周强,王中新.铜绿假单胞菌对亚胺培南耐药机制的研究[J].中华微生物学和免疫学杂志,2005,25(5):427-427. 被引量:8
  • 3韩黎,朱士俊,郭燕红,李六亿,胡必杰,武迎宏,袁云娥.中国医务人员执行手卫生的现状调查[J].中华医院感染学杂志,2006,16(2):140-142. 被引量:630
  • 4陈瑞,唐英春,朱家馨,李建国,彭湘民.耐亚胺培南铜绿假单胞菌的耐药性及分子流行病学研究[J].中华医院感染学杂志,2006,16(4):371-373. 被引量:36
  • 5National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. M100-S12[S]. Pennsylvania:NCCLS, 2002. 1-133.
  • 6Yong D, Lee K, Yum JH,et al. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp[ J ]. J Clin Microbiol, 2002,40 ( 10 ) : 3798-3801.
  • 7[2]National Committee for clinical Laboratory standards.Performance standards for antimicrobial susceotibility testing[S].8th informational supplemental standard PA,NCCLS,1999.36.
  • 8[3]National Committee for clinical Laboratory standards.Performance standards for antimicrobial susceotibility testing[M].Eleventh informational supplement.M100-S11:pennsy lvania:NCCLS,2001.
  • 9[5]VILLERS D,ESPAZE E,COSTER BM.Nosocomial and clinical epide miology[J].Ann Intern.Med,1998,129(3):182.
  • 10[6]SIHAM M,JIMMIE X,WURLS R,et al.Underlying Characteristices of patients harboring highly resistant Acinetobacter baumannii[J].Am J Infect control,2002,30(7):386.

共引文献54

同被引文献43

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部